Danske Bank A S Makes New $32.56 Million Investment in Agilent Technologies, Inc. $A

Danske Bank A S bought a new stake in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 245,094 shares of the medical research company’s stock, valued at approximately $32,556,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Fiduciary Trust Co raised its holdings in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares during the last quarter. Sapient Capital LLC grew its holdings in Agilent Technologies by 4.2% during the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after acquiring an additional 85 shares during the last quarter. Plan A Wealth LLC increased its position in Agilent Technologies by 3.2% in the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after acquiring an additional 92 shares during the period. UNIVEST FINANCIAL Corp increased its position in Agilent Technologies by 1.3% in the 2nd quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock valued at $949,000 after acquiring an additional 93 shares during the period. Finally, IHT Wealth Management LLC raised its stake in shares of Agilent Technologies by 4.9% during the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares during the last quarter.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Barclays lifted their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price objective for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Finally, HSBC decreased their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Trading Up 4.7%

NYSE:A opened at $155.40 on Thursday. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The firm’s fifty day moving average is $136.44 and its 200-day moving average is $125.84. The firm has a market cap of $43.89 billion, a P/E ratio of 31.20, a P/E/G ratio of 2.63 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.